Dustin Sjuts
Geen lopende functies
Vermogen: 824 346 $ op 31-03-2024
Profiel
Dustin S.
Sjuts worked as the Business Unit Head-China at Galderma Holding SA from 2017 to 2018.
He then served as the President at Revance Therapeutics, Inc. from 2021 to 2024.
Prior to his professional experience, he completed his undergraduate degree at Illinois State University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-03-2024 | 167 550 ( 0.16% ) | 824 346 $ | 31-03-2024 |
Eerdere bekende functies van Dustin Sjuts
| Bedrijven | Functie | Einde |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | President | 31-03-2024 |
Galderma Holding SA
 Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Corporate Officer/Principal | 01-04-2018 |
Opleiding van Dustin Sjuts
| Illinois State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| REVANCE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Galderma Holding SA
Galderma Holding SA Pharmaceuticals: MajorHealth Technology Galderma Holding SA owns shares and interest of manufacturers and distributors of dermatological and skin care products. The company is headquartered in La Tour-de-Peilz, Swtzerland. | Health Technology |
